4.7 Article

Role of the prostanoid EP4 receptor in iloprost-mediated vasodilatation in pulmonary hypertension

Related references

Note: Only part of the references are listed.
Article Cardiac & Cardiovascular Systems

Phosphodiesterase 1 upregulation in pulmonary arterial hypertension target for reverse-remodeling therapy

Ralph Theo Schermuly et al.

CIRCULATION (2007)

Article Respiratory System

Iloprost-induced desensitization of the prostacyclin receptor in isolated rabbit lungs

Ralph T. Schermuly et al.

RESPIRATORY RESEARCH (2007)

Review Hematology

Nitric oxide in the pulmonary vasculature

Matthew P. Coggins et al.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)

Article Pharmacology & Pharmacy

Prostaglandin E2 receptor EP4 contributes to inflammatory pain hypersensitivity

Chung-Ren Lin et al.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)

Review Biotechnology & Applied Microbiology

Sildenafil: from angina to erectile dysfunction to pulmonary hypertension and beyond

Hossein A. Ghofrani et al.

NATURE REVIEWS DRUG DISCOVERY (2006)

Article Medicine, Research & Experimental

Reversal of experimental pulmonary hypertension by PDGF inhibition

RT Schermuly et al.

JOURNAL OF CLINICAL INVESTIGATION (2005)

Article Critical Care Medicine

Inhaled lloprost reverses vascular remodeling in chronic experimental pulmonary hypertension

RT Schermuly et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2005)

Article Critical Care Medicine

Antiproliferative effects of phosphodiesterase type 5 inhibition in human pulmonary artery cells

J Wharton et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2005)

Article Physiology

Prostanoid receptor expression by human airway smooth muscle cells and regulation of the secretion of granulocyte colony-stimulating factor

DL Clarke et al.

AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2005)

Article Pharmacology & Pharmacy

EP4 prostanoid receptor-mediated vasodilatation of human middle cerebral arteries

RJ Davis et al.

BRITISH JOURNAL OF PHARMACOLOGY (2004)

Article Critical Care Medicine

A combination of oral sildenafil and beraprost ameliorates pulmonary hypertension in rats

T Itoh et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2004)

Article Pharmacology & Pharmacy

Functional pharmacology of human prostanoid EP2 and EP4 receptors

RJ Wilson et al.

EUROPEAN JOURNAL OF PHARMACOLOGY (2004)

Article Cardiac & Cardiovascular Systems

Serotonin-induced smooth muscle hyperplasia in various forms of human pulmonary hypertension

E Marcos et al.

CIRCULATION RESEARCH (2004)

Article Cardiac & Cardiovascular Systems

Beraprost therapy for pulmonary arterial hypertension

RJ Barst et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2003)

Article Medicine, General & Internal

Inhaled iloprost for severe pulmonary hypertension

H Olschewski et al.

NEW ENGLAND JOURNAL OF MEDICINE (2002)

Article Biochemistry & Molecular Biology

Differential effects of stable prostacyclin analogs on smooth muscle proliferation and cyclic AMP generation in human pulmonary artery

LH Clapp et al.

AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2002)

Article Biochemistry & Molecular Biology

Prostacyclin analogs as the brakes for pulmonary artery smooth muscle cell proliferation - Is it sufficient to treat severe pulmonary hypertension?

RM Tuder et al.

AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2002)

Article Critical Care Medicine

Prostacyclin receptor-dependent modulation of pulmonary vascular remodeling

Y Hoshikawa et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2001)

Review Pharmacology & Pharmacy

Prostanoid receptors: Subtypes and signaling

RM Breyer et al.

ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2001)

Article Biochemistry & Molecular Biology

Complete reversal of fatal pulmonary hypertension in rats by a serine elastase inhibitor

KN Cowan et al.

NATURE MEDICINE (2000)

Article Medicine, General & Internal

Inhaled iloprost to treat severe pulmonary hypertension -: An uncontrolled trial

H Olschewski et al.

ANNALS OF INTERNAL MEDICINE (2000)

Article Cardiac & Cardiovascular Systems

A comparison of the acute hemodynamic effects of inhaled nitric oxide and aerosolized iloprost in primary pulmonary hypertension

MM Hoeper et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2000)